DexCom, Inc. DXCM

DXCM Company Overview

DexCom, Inc. is a U.S.-based medical device company focused on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for people with diabetes and related metabolic conditions. The company operates within the medical technology and digital health industries, with its primary business centered on wearable glucose sensing devices that provide real-time glucose readings to patients and healthcare providers. DexCom’s products are widely used by individuals with Type 1 and Type 2 diabetes and are integrated with insulin delivery systems, smartphones, and digital health platforms. Its primary revenue drivers are recurring sensor sales, transmitters, receivers, and associated software services tied to its CGM ecosystem.

The company’s flagship products include the Dexcom G6 and Dexcom G7 CGM systems, which are designed to improve glucose management through continuous data monitoring and alerts. DexCom has positioned itself as a leading independent CGM provider through strong clinical validation, broad payer coverage, and interoperability with insulin pumps and connected health applications. Founded in 1999 and headquartered in San Diego, California, DexCom evolved from an early-stage glucose sensing technology company into a global diabetes technology leader through product innovation, regulatory approvals, and strategic partnerships with healthcare and technology firms.